Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer. [electronic resource] by
- Madajewicz, Stefan
- Waterhouse, David M
- Ritch, Paul S
- Khan, M Qaseem
- Higby, Donald J
- Leichman, Cynthia G
- Malik, Sandeep K
- Hentschel, Patricia
- Gill, John F
- Zhao, Luping
- Nicol, Steven J
Producer: 20120611
In:
Investigational new drugs vol. 30
Availability: No items available.
|